The COP9 signalosome interacts with and regulates interferon regulatory factor 5 protein stability

Molecular and Cellular Biology

Volumn 33, Issue 6, 2013, Pages 1114-1123

  Korczeniewska, Justyna ^a   Barnes, Betsy ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; COP9 SIGNALOSOME; INTERFERON REGULATORY FACTOR 5; PROTEASOME; SMALL INTERFERING RNA; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; UBIQUITIN;

AMINO TERMINAL SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; GENE DELETION; GENE SILENCING; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; PHARMACOLOGICAL BLOCKING; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; PROTEOMICS; RNA INTERFERENCE;

EID: 84878780272     PISSN: 02707306     EISSN: 10985549     Source Type: Journal    
DOI: 10.1128/MCB.00802-12     Document Type: Article

References (86)

1. Savitsky D, Tamura T, Yanai H, Taniguchi T. 2010. Regulation of immunity and oncogenesis by the IRF transcription factor family. Cancer Immunol. Immunother. 59:489 -510.
2. Barnes BJ, Moore PA, Pitha PM. 2001. Virus-specific activation of a novel interferon regulatory factor, IRF-5, results in the induction of distinct interferon alpha genes. J. Biol. Chem. 276:23382-23390.
3. Takaoka A, Yanai H, Kondo S, Duncan G, Negishi H, Mizutani T, Kano S, Honda K, Ohba Y, Mak TW, Taniguchi T. 2005. Integral role of IRF-5 in the gene induction programme activated by Toll-like receptors. Nature 434:243-249.
4. Yanai H, Chen HM, Inuzuka T, Kondo S, Mak TW, Takaoka A, Honda K, Taniguchi T. 2007. Role of IFN regulatory factor 5 transcription factor in antiviral immunity and tumor suppression. Proc. Natl. Acad. Sci. U. S. A. 104:3402-3407.
5. Feng D, Stone RC, Eloranta ML, Sangster-Guity N, Nordmark G, Sigurdsson S, Wang C, Alm G, Syvanen AC, Ronnblom L, Barnes BJ. 2010. Genetic variants and disease-associated factors contribute to enhanced interferon regulatory factor 5 expression in blood cells of patients with systemic lupus erythematosus. Arthritis Rheum. 62:562-573.
6. Miceli-Richard C, Comets E, Loiseau P, Puechal X, Hachulla E, Mariette X. 2007. Association of an IRF5 gene functional polymorphism with Sjogren's syndrome. Arthritis Rheum. 56:3989 -3994.
7. Rueda B, Reddy MV, Gonzalez-Gay MA, Balsa A, Pascual-Salcedo D, Petersson IF, Eimon A, Paira S, Scherbarth HR, Pons-Estel BA, Gonzalez- Escribano MF, Alarcon-Riquelme ME, Martin J. 2006. Analysis of IRF5 gene functional polymorphisms in rheumatoid arthritis. Arthritis Rheum. 54:3815-3819.
8. Sigurdsson S, Nordmark G, Goring HH, Lindroos K, Wiman AC, Sturfelt G, Jonsen A, Rantapaa-Dahlqvist S, Moller B, Kere J, Koskenmies S, Widen E, Eloranta ML, Julkunen H, Kristjansdottir H, Steinsson K, Alm G, Ronnblom L, Syvanen AC. 2005. Polymorphisms in the tyrosine kinase 2 and interferon regulatory factor 5 genes are associated with systemic lupus erythematosus. Am. J. Hum. Genet. 76:528 -537.
9. Sigurdsson S, Padyukov L, Kurreeman FA, Liljedahl U, Wiman AC, Alfredsson L, Toes R, Ronnelid J, Klareskog L, Huizinga TW, Alm G, Syvanen AC, Ronnblom L. 2007. Association of a haplotype in the promoter region of the interferon regulatory factor 5 gene with rheumatoid arthritis. Arthritis Rheum. 56:2202-2210.
10. Barnes BJ, Kellum MJ, Pinder KE, Frisancho JA, Pitha PM. 2003. Interferon regulatory factor 5, a novel mediator of cell cycle arrest and cell death. Cancer Res. 63:6424-6431.
11. Couzinet A, Tamura K, Chen HM, Nishimura K, Wang Z, Morishita Y, Takeda K, Yagita H, Yanai H, Taniguchi T, Tamura T. 2008. A cell type- specific requirement for IFN regulatory factor 5 (IRF5) in Fasinduced apoptosis. Proc. Natl. Acad. Sci. U. S. A. 105:2556 -2561.
12. Hu G.Barnes BJ. 2009. IRF-5 is a mediator of the death receptor-induced apoptotic signaling pathway. J. Biol. Chem. 284:2767-2777.
13. Hu G, Mancl ME, Barnes BJ. 2005. Signaling through IFN regulatory factor-5 sensitizes p53-deficient tumors to DNA damage-induced apoptosis and cell death. Cancer Res. 65:7403-7412.
14. Mori T, Anazawa Y, Iiizumi M, Fukuda S, Nakamura Y, Arakawa H. 2002. Identification of the interferon regulatory factor 5 gene (IRF-5) as a direct target for p53. Oncogene 21:2914 -2918.
15. Bi X, Hameed M, Mirani N, Pimenta EM, Anari J, Barnes BJ. 2011. Loss of interferon regulatory factor 5 (IRF5) expression in human ductal carcinoma correlates with disease stage and contributes to metastasis. Breast Cancer Res. 13:R111. doi:10.1186/bcr3053.
16. Izaguirre A, Barnes BJ, Amrute S, Yeow WS, Megjugorac N, Dai J, Feng D, Chung E, Pitha PM, Fitzgerald-Bocarsly P. 2003. Comparative analysis of IRF and IFN-alpha expression in human plasmacytoid and monocyte- derived dendritic cells. J. Leukoc. Biol. 74:1125-1138.
17. Mancl ME, Hu G, Sangster-Guity N, Olshalsky SL, Hoops K, Fitzgerald- Bocarsly P, Pitha PM, Pinder K, Barnes BJ. 2005. Two discrete promoters regulate the alternatively spliced human interferon regulatory factor-5 isoforms. Multiple isoforms with distinct cell type-specific expression, localization, regulation, and function. J. Biol. Chem. 280:21078 -21090.
18. Balkhi MY, Fitzgerald KA, Pitha PM. 2008. Functional regulation of MyD88-activated interferon regulatory factor 5 by K63-linked polyubiquitination. Mol. Cell. Biol. 28:7296 -7308.
19. Barnes BJ, Kellum MJ, Field AE, Pitha PM. 2002. Multiple regulatory domains of IRF-5 control activation, cellular localization, and induction of chemokines that mediate recruitment of T lymphocytes. Mol. Cell. Biol. 22:5721-5740.
20. Chang Foreman HC, Van Scoy S, Cheng TF, Reich NC. 2012. Activation of interferon regulatory factor 5 by site specific phosphorylation. PLoS One 7:e33098. doi:10.1371/journal.pone.0033098.
21. Cheng TF, Brzostek S, Ando O, Van Scoy S, Kumar KP, Reich NC. 2006. Differential activation of IFN regulatory factor (IRF)-3 and IRF-5 transcription factors during viral infection. J. Immunol. 176:7462-7470.
22. Feng D, Sangster-Guity N, Stone R, Korczeniewska J, Mancl ME, Fitzgerald-Bocarsly P, Barnes BJ. 2010. Differential requirement of histone acetylase and deacetylase activities for IRF5-mediated proinflammatory cytokine expression. J. Immunol. 185:6003- 6012.
23. Barnes BJ Field AE, Pitha-Rowe PM. 2003. Virus-induced heterodimer formation between IRF-5 and IRF-7 modulates assembly of the IFNA enhanceosome in vivo and transcriptional activity of IFNA genes. J. Biol. Chem. 278:16630 -16641.
24. Seeger M, Kraft R, Ferrell K, Bech-Otschir D, Dumdey R, Schade R, Gordon C, Naumann M, Dubiel W. 1998. A novel protein complex involved in signal transduction possessing similarities to 26S proteasome subunits. FASEB J. 12:469-478.
25. Wei N, Tsuge T, Serino G, Dohmae N, Takio K, Matsui M, Deng XW. 1998. The COP9 complex is conserved between plants and mammals and is related to the 26S proteasome regulatory complex. Curr. Biol. 8:919- 922.
26. Chamovitz DA, Wei N, Osterlund MT, von Arnim AG, Staub JM, Matsui M, Deng XW. 1996. The COP9 complex, a novel multisubunit nuclear regulator involved in light control of a plant developmental switch. Cell 86:115-121.
27. Wei N, Chamovitz DA, Deng XW. 1994. Arabidopsis COP9 is a component of a novel signaling complex mediating light control of development. Cell 78:117-124.
28. Wei N, Deng XW. 1999. Making sense of the COP9 signalosome. A regulatory protein complex conserved from Arabidopsis to human. Trends Genet. 15:98 -103.
29. Mundt KE, Porte J, Murray JM, Brikos C, Christensen PU, Caspari T, Hagan IM, Millar JB, Simanis V, Hofmann K, Carr AM. 1999. The COP9/signalosome complex is conserved in fission yeast and has a role in S phase. Curr. Biol. 9:1427-1430.
30. Busch S, Eckert SE, Krappmann S, Braus GH. 2003. The COP9 signalosome is an essential regulator of development in the filamentous fungus Aspergillus nidulans. Mol. Microbiol. 49:717-730.
31. Luke-Glaser S, Roy M, Larsen B, Le Bihan T, Metalnikov P, Tyers M, Peter M, Pintard L. 2007. CIF-1, a shared subunit of the COP9/ signalosome and eukaryotic initiation factor 3 complexes, regulates MEL-26 levels in the Caenorhabditis elegans embryo. Mol. Cell. Biol. 27: 4526-4540.
32. Bech-Otschir D, Seeger M, Dubiel W. 2002. The COP9 signalosome: at the interface between signal transduction and ubiquitin-dependent proteolysis. J. Cell Sci. 115:467- 473.
33. Cope GA, Deshaies RJ. 2003. COP9 signalosome: a multifunctional regulator of SCF and other cullin-based ubiquitin ligases. Cell 114:663- 671. 34. Schwechheimer C. 2004. The COP9 signalosome (CSN): an evolutionary conserved proteolysis regulator in eukaryotic development. Biochim. Biophys. Acta 1695:45-54.
34. Schwechheimer C. 2004. The COP9 signalosome (CSN): an evolutionary conserved proteolysis regulator in eukaryotic development. Biochim. Biophys. Acta 1695:45-54.
35. von Arnim AG. 2003. On again-off again: COP9 signalosome turns the key on protein degradation. Curr. Opin. Plant Biol. 6:520 -529.
36. Wei N, Deng XW. 2003. The COP9 signalosome. Annu. Rev. Cell Dev. Biol. 19:261-286.
37. Wolf DA, Zhou C, Wee S. 2003. The COP9 signalosome: an assembly and maintenance platform for cullin ubiquitin ligases? Nat. Cell Biol. 5:1029- 1033.
38. Harari-Steinberg O, Chamovitz DA. 2004. The COP9 signalosome: mediating between kinase signaling and protein degradation. Curr. Protein Pept. Sci. 5:185-189.
39. Kim JH, Choi JK, Cinghu S, Jang JW, Lee YS, Li YH, Goh YM, Chi XZ, Lee KS, Wee H, Bae SC. 2009. Jab1/CSN5 induces the cytoplasmic localization and degradation of RUNX3. J. Cell. Biochem. 107:557-565.
40. Oh W, Lee EW, Sung YH, Yang MR, Ghim J, Lee HW, Song J. 2006. Jab1 induces the cytoplasmic localization and degradation of p53 in coordination with Hdm2. J. Biol. Chem. 281:17457-17465.
41. Jiang X, Coffino P, Li X. 2004. Development of a method for screening short-lived proteins using green fluorescent protein. Genome Biol. 5:R81. doi:10.1186/gb-2004-5-10-r81.
42. Stone RC, Feng D, Deng J, Singh S, Yang L, Fitzgerald-Bocarsly P, Eloranta ML, Ronnblom L, Barnes BJ. 2012. Interferon regulatory factor 5 activation in monocytes of systemic lupus erythematosus patients is triggered by circulating autoantigens independent of type I interferons. Arthritis Rheum. 64:788 -798.
43. Kurnellas MP, Li H, Jain MR, Giraud SN, Nicot AB, Ratnayake A, Heary RF, Elkabes S. 2010. Reduced expression of plasma membrane calcium ATPase 2 and collapsin response mediator protein 1 promotes death of spinal cord neurons. Cell Death Differ. 17:1501-1510.
44. Hoareau Alves K, Bochard V, Rety S, Jalinot P. 2002. Association of the mammalian proto-oncoprotein Int-6 with the three protein complexes eIF3, COP9 signalosome and 26S proteasome. FEBS Lett. 527:15-21.
45. Uhle S, Medalia O, Waldron R, Dumdey R, Henklein P, Bech-Otschir D, Huang X, Berse M, Sperling J, Schade R, Dubiel W. 2003. Protein kinase CK2 and protein kinase D are associated with the COP9 signalosome. EMBO J. 22:1302-1312.
46. Wang Y, Devereux W, Stewart TM, Casero RA, Jr. 2001. Characterization of the interaction between the transcription factors human polyamine modulated factor (PMF-1) and NF-E2-related factor 2 (Nrf-2) in the transcriptional regulation of the spermidine/spermine N1- acetyltransferase (SSAT) gene. Biochem. J. 355:45- 49.
47. Bech-Otschir D, Kraft R, Huang X, Henklein P, Kapelari B, Pollmann C, Dubiel W. 2001. COP9 signalosome-specific phosphorylation targets p53 to degradation by the ubiquitin system. EMBO J. 20:1630 -1639.
48. Sun Y, Wilson MP, Majerus PW. 2002. Inositol 1,3,4-trisphosphate 5/6-kinase associates with the COP9 signalosome by binding to CSN1. J. Biol. Chem. 277:45759-45764.
49. Wilson MP, Sun Y, Cao L, Majerus PW. 2001. Inositol 1,3,4- trisphosphate 5/6-kinase is a protein kinase that phosphorylates the transcription factors c-Jun and ATF-2. J. Biol. Chem. 276:40998-41004.
50. Tomoda K, Kubota Y, Arata Y, Mori S, Maeda M, Tanaka T, Yoshida M, Yoneda-Kato N, Kato JY. 2002. The cytoplasmic shuttling and subsequent degradation of p27Kip1 mediated by Jab1/CSN5 and the COP9 signalosome complex. J. Biol. Chem. 277:2302-2310.
51. Chen W, Lam SS, Srinath H, Jiang Z, Correia JJ, Schiffer CA, Fitzgerald KA, Lin K, Royer WE, Jr. 2008. Insights into interferon regulatory factor activation from the crystal structure of dimeric IRF5. Nat. Struct. Mol. Biol. 15:1213-1220.
52. Peth A, Berndt C, Henke W, Dubiel W. 2007. Downregulation of COP9 signalosome subunits differentially affects the CSN complex and target protein stability. BMC Biochem. 8:27. doi:10.1186/1471-2091-8-27.
53. Dornan D, Wertz I, Shimizu H, Arnott D, Frantz GD, Dowd P, O'Rourke K, Koeppen H, Dixit VM. 2004. The ubiquitin ligase COP1 is a critical negative regulator of p53. Nature 429:86 -92.
54. Hetfeld BK, Bech-Otschir D, Dubiel W. 2005. Purification method of the COP9 signalosome from human erythrocytes. Methods Enzymol. 398: 481-491.
55. Luo J, Emanuele MJ, Li D, Creighton CJ, Schlabach MR, Westbrook TF, Wong KK, Elledge SJ. 2009. A genome-wide RNAi screen identifies multiple synthetic lethal interactions with the Ras oncogene. Cell 137: 835-848.
56. Shiloh Y. 2006. The ATM-mediated DNA-damage response: taking shape. Trends Biochem. Sci. 31:402- 410.
57. Tomoda K, Kato JY, Tatsumi E, Takahashi T, Matsuo Y, Yoneda-Kato N. 2005. The Jab1/COP9 signalosome subcomplex is a downstream mediator of Bcr-Abl kinase activity and facilitates cell-cycle progression. Blood 105:775-783.
58. Tomoda K, Kubota Y, Kato J. 1999. Degradation of the cyclindependent- kinase inhibitor p27Kip1 is instigated by Jab1. Nature 398: 160-165.
59. Yoneda-Kato N, Tomoda K, Umehara M, Arata Y, Kato JY. 2005. Myeloid leukemia factor 1 regulates p53 by suppressing COP1 via COP9 signalosome subunit 3. EMBO J. 24:1739 -1749.
60. Schoenemeyer A, Barnes BJ, Mancl ME, Latz E, Goutagny N, Pitha PM, Fitzgerald KA, Golenbock DT. 2005. The interferon regulatory factor, IRF5, is a central mediator of Toll-like receptor 7 signaling. J. Biol. Chem. 280:17005-17012.
61. Brass AL, Zhu AQ, Singh H. 1999. Assembly requirements of PU.1-Pip (IRF-4) activator complexes: inhibiting function in vivo using fused dimers. EMBO J. 18:977-991.
62. Eklund EA, Jalava A, Kakar R. 1998. PU.1, interferon regulatory factor 1, and interferon consensus sequence-binding protein cooperate to increase gp91(phox) expression. J. Biol. Chem. 273:13957-13965.
63. Kantakamalakul W, Politis AD, Marecki S, Sullivan T, Ozato K, Fenton MJ, Vogel SN. 1999. Regulation of IFN consensus sequence binding protein expression in murine macrophages. J. Immunol. 162:7417-7425.
64. Sharf R, Azriel A, Lejbkowicz F, Winograd SS, Ehrlich R, Levi BZ. 1995. Functional domain analysis of interferon consensus sequence binding protein (ICSBP) and its association with interferon regulatory factors. J. Biol. Chem. 270:13063-13069.
65. Cohen H, Azriel A, Cohen T, Meraro D, Hashmueli S, Bech-Otschir D, Kraft R, Dubiel W, Levi BZ. 2000. Interaction between interferon consensus sequence-binding protein and COP9/signalosome subunit CSN2 (Trip15). A possible link between interferon regulatory factor signaling and the COP9/signalosome. J. Biol. Chem. 275:39081-39089.
66. Schweitzer K, Bozko PM, Dubiel W, Naumann M. 2007. CSN controls NF-kappaB by deubiquitinylation of IkappaBalpha. EMBO J. 26:1532- 1541.
67. Schweitzer K, Naumann M. 2010. Control of NF-kappaB activation by the COP9 signalosome. Biochem. Soc. Trans. 38:156 -161.
68. Naumann M, Bech-Otschir D, Huang X, Ferrell K, Dubiel W. 1999. COP9 signalosome-directed c-Jun activation/stabilization is independent of JNK. J. Biol. Chem. 274:35297-35300.
69. Kato JY, Yoneda-Kato N. 2009. Mammalian COP9 signalosome. Genes Cells 14:1209 -1225.
70. McCulloch CA, Downey GP, El-Gabalawy H. 2006. Signalling platforms that modulate the inflammatory response: new targets for drug development. Nat. Rev. Drug Discov. 5:864-876.
71. Bondar T, Kalinina A, Khair L, Kopanja D, Nag A, Bagchi S, Raychaudhuri P. 2006. Cul4A and DDB1 associate with Skp2 to target p27Kip1 for proteolysis involving the COP9 signalosome. Mol. Cell. Biol. 26:2531-2539.
72. Menon S, Chi H, Zhang H, Deng XW, Flavell RA, Wei N. 2007. COP9 signalosome subunit 8 is essential for peripheral T cell homeostasis and antigen receptor-induced entry into the cell cycle from quiescence. Nat. Immunol. 8:1236 -1245.
73. Panattoni M, Sanvito F, Basso V, Doglioni C, Casorati G, Montini E, Bender JR, Mondino A, Pardi R. 2008. Targeted inactivation of the COP9 signalosome impairs multiple stages of T cell development. J. Exp. Med. 205:465- 477.
74. Yang X, Menon S, Lykke-Andersen K, Tsuge T, Di X, Wang X, Rodriguez- Suarez RJ, Zhang H, Wei N. 2002. The COP9 signalosome inhibits p27(kip1) degradation and impedes G1-S phase progression via deneddylation of SCF Cul1. Curr. Biol. 12:667- 672.
75. Fukumoto A, Tomoda K, Kubota M, Kato JY, Yoneda-Kato N. 2005. Small Jab1-containing subcomplex is regulated in an anchorage- and cell cycle-dependent manner, which is abrogated by ras transformation. FEBS Lett. 579:1047-1054.
76. Dornan D, Shimizu H, Mah A, Dudhela T, Eby M, O'Rourke K, Seshagiri S, Dixit VM. 2006. ATM engages autodegradation of the E3 ubiquitin ligase COP1 after DNA damage. Science 313:1122-1126.
77. Higa LA, Mihaylov IS, Banks DP, Zheng J, Zhang H. 2003. Radiationmediated proteolysis of CDT1 by CUL4-ROC1 and CSN complexes constitutes a new checkpoint. Nat. Cell Biol. 5:1008 -1015.
78. Huang J, Yuan H, Lu C, Liu X, Cao X, Wan M. 2007. Jab1 mediates protein degradation of the Rad9-Rad1-Hus1 checkpoint complex. J. Mol. Biol. 371:514 -527.
79. Matsuoka S, Ballif BA, Smogorzewska A, McDonald ER, III, Hurov KE, Luo J, Bakalarski CE, Zhao Z, Solimini N, Lerenthal Y, Shiloh Y, Gygi SP, Elledge SJ. 2007. ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage. Science 316:1160 -1166.
80. da Silva Correia J, Miranda Y, Leonard N, Ulevitch RJ. 2007. The subunit CSN6 of the COP9 signalosome is cleaved during apoptosis. J. Biol. Chem. 282:12557-12565.
81. Hetfeld BK, Peth A, Sun XM, Henklein P, Cohen GM, Dubiel W. 2008. The COP9 signalosome-mediated deneddylation is stimulated by caspases during apoptosis. Apoptosis 13:187-195.
82. Pearce C, Hayden RE, Bunce CM, Khanim FL. 2009. Analysis of the role of COP9 Signalosome (CSN) subunits in K562; the first link between CSN and autophagy. BMC Cell Biol. 10:31. doi:10.1186/1471-2121-10-31.
83. Lee MH, Zhao R, Phan L, Yeung SC. 2011. Roles of COP9 signalosome in cancer. Cell Cycle 10:3057-3066.
84. Zhao R, Yeung SC, Chen J, Iwakuma T, Su CH, Chen B, Qu C, Zhang F, Chen YT, Lin YL, Lee DF, Jin F, Zhu R, Shaikenov T, Sarbassov D, Sahin A, Wang H, Lai CC, Tsai FJ, Lozano G, Lee MH. 2011. Subunit 6 of the COP9 signalosome promotes tumorigenesis in mice through stabilization of MDM2 and is upregulated in human cancers. J. Clin. Invest. 121:851- 865.
85. Deng Z, Pardi R, Cheadle W, Xiang X, Zhang S, Shah SV, Grizzle W, Miller D, Mountz J, Zhang HG. 2011. Plant homologue constitutive photomorphogenesis 9 (COP9) signalosome subunit CSN5 regulates innate immune responses in macrophages. Blood 117:4796-4804.
86. Stone RC, Du P, Feng D, Dhawan K, Rönnblom L, Eloranta ML, Donnelly R, Barnes BJ. 2013. RNA-Seq for enrichment and analysis of IRF5 transcript expression in SLE. PLoS ONE 8:e54487. doi:10.1371 /journal.pone.0054487.